跳至主要内容
临床试验/ISRCTN14973494
ISRCTN14973494已完成未知

COVID anxiety: Risks, consequences and feasibility trial

Imperial College London0 个研究点目标入组 40 人开始时间: 2021年9月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36691181/ (added 24/01/2023) 2024 Results article in https://doi.org/10.1186/s12888-023-05446-9 (added 08/01/2024)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Age 18 or over
  • 2. Score 9 or more on the Covid Anxiety Scale
  • Additionally for the nested feasibility trial
  • 3. Score 20 or more on the Health Anxiety Inventory

排除标准

  • 1. A current or previous diagnosis of a psychotic mental disorder
  • Additionally for the nested feasibility trial
  • 2. Has had COVID-19 within the last 4 weeks (defined as a positive antigen test or a diagnosis from a clinician)
  • 3. Has been told, either by a doctor or the NHS Test and Trace service, that they should self-isolate due to the possibility that they have been exposed to covid-19
  • 4. Currently in receipt of a psychological treatment

研究者

相似试验